Cargando…
A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure
AIMS: Heart failure (HF) is frequently caused by an ischaemic event (e.g. myocardial infarction) but might also be caused by a primary disease of the myocardium (cardiomyopathy). In order to identify targeted therapies specific for either ischaemic or non‐ischaemic HF, it is important to better unde...
Autores principales: | Sama, Iziah E., Woolley, Rebecca J., Nauta, Jan F., Romaine, Simon P.R., Tromp, Jasper, ter Maaten, Jozine M., van der Meer, Peter, Lam, Carolyn S.P., Samani, Nilesh J., Ng, Leong L., Metra, Marco, Dickstein, Kenneth, Anker, Stefan D., Zannad, Faiez, Lang, Chim C., Cleland, John G.F., van Veldhuisen, Dirk J., Hillege, Hans L., Voors, Adriaan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319432/ https://www.ncbi.nlm.nih.gov/pubmed/32243695 http://dx.doi.org/10.1002/ejhf.1811 |
Ejemplares similares
-
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targets
por: Cao, Thong H., et al.
Publicado: (2019) -
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
por: ter Maaten, Jozine M., et al.
Publicado: (2020) -
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT‐CHF
por: Pagnesi, Matteo, et al.
Publicado: (2021) -
Clinical implications of low estimated protein intake in patients with heart failure
por: Streng, Koen W., et al.
Publicado: (2022) -
Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction
por: Woolley, Rebecca J., et al.
Publicado: (2021)